| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 124, 1918-1924, Copyright © 1989 by Endocrine Society
ARTICLES |
HV Strout, PP Vicario, R Saperstein and EE Slater
Department of Biochemical Endocrinology, Merck, Sharp, and Dohme Research Laboratories, Rahway, New Jerey 07065.
The in vivo administration of sodium orthovanadate stimulated the incorporation of [14C]glucose into [14C] glycogen, in a dose- and time- dependent manner, in mouse diaphragm. Activation of diaphragm insulin receptor was measured by exogenous tyrosine kinase activity and an antibody that recognizes a conformational change in the receptor beta- subunit upon autophosphorylation. Neither method detected insulin receptor activation by in vivo vanadate administration, suggesting that vanadate's insulin-mimetic effect on mouse diaphragm glycogenesis occurs at a site distal to the insulin receptor.
This article has been cited by other articles:
![]() |
K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. P. Redondo Vanadyl Sulfate Improves Hepatic and Muscle Insulin Sensitivity in Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1410 - 1417. [Abstract] [Full Text] |
||||
![]() |
I. Goldwaser, S. Qian, E. Gershonov, M. Fridkin, and Y. Shechter Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators Mol. Pharmacol., October 1, 2000; 58(4): 738 - 746. [Abstract] [Full Text] |
||||
![]() |
I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sekar, J. Li, Z. He, D. Gefel, and Y. Shechter Independent Signal-Transduction Pathways for Vanadate and for Insulin in the Activation of Glycogen Synthase and Glycogenesis in Rat Adipocytes Endocrinology, March 1, 1999; 140(3): 1125 - 1131. [Abstract] [Full Text] |
||||
![]() |
J. Li, G. Elberg, N. Sekar, Z. B. He, and Y. Shechter Antilipolytic Actions of Vanadate and Insulin in Rat Adipocytes Mediated by Distinctly Different Mechanisms Endocrinology, June 1, 1997; 138(6): 2274 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Kole, M. J. Garant, S. Kole, and M. Bernier A Peptide-based Protein-tyrosine Phosphatase Inhibitor Specifically Enhances Insulin Receptor Function in Intact Cells J. Biol. Chem., June 14, 1996; 271(24): 14302 - 14307. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4) J. Biol. Chem., September 14, 2001; 276(38): 35589 - 35598. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |